The Redsense device is now introduced at the facilities of the Rogosin Institute, long recognized as one of the premier centers in the US for kidney disease diagnosis and management. The institute, which ranks among the top 10 dialysis providers in the US, operates nine dialysis centers in the NYC area with about 1,500 patients on hemodialysis. In addition to this, 10 patients undergoing treatment at the Dialysis Center of Lincoln, Inc. have also begun to use the Redsense device. DCL Inc. operates several centers in the Omaha, Nebraska area.

"The decision by these providers to adopt Redsense's technology primarily benefits patient security, as the device adds another layer of security to hemodialysis. For us as a company, it further strengthens our goal to establish the Redsense alarm system as a standard protection measure agains venous needle dislodgement," says Patrik Byhmer, CEO of Redsense Medical AB.